Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.48.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CJ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.377NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.5.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.86 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.7 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.12 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.7.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.390NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.317NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.397NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.277NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.294NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.413NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.268NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.409NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.587NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.232NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.5.2.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used